Milestone scientific announces 510(k) fda clearance for the use of compuflo epidural system in thoracic indications

Roseland, nj., feb. 27, 2023 (globe newswire) -- milestone scientific inc. (nyse:mlss), a leading developer of computerized drug delivery instruments that provides painless and precise injections, today announced that its compuflo® epidural system has received 510(k) fda clearance for use in the thoracic region of the spine, including the cervical thoracic junction. this approval expands upon the company's prior approval of compuflo for use within the lumbar region of the spine, where the focus has been on labor and delivery.
MLSS Ratings Summary
MLSS Quant Ranking